Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8376336 | 0.93 | MEN1 (0.47) | MEN1KMT2AIDO1CHRM2HTT | |
| SCHEMBL6604781 | 0.79 | KMT2A (0.56) | MEN1KMT2AHTTMAPTLMNA | |
| SCHEMBL20435360 | 0.79 | TAAR1 (0.50) | MEN1KMT2AIDO1APPSMN1; SMN2 | |
| SCHEMBL20287965 | 0.79 | ALDH1A1 (0.44) | MEN1KMT2AIDO1HTTMAPT | |
| SCHEMBL6578267 | 0.78 | CYP3A4 (0.62) | IDO1APPSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL7668721 | 0.77 | IDO1 (0.52) | IDO1APPSMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL6575981 | 0.77 | MEN1 (0.54) | MEN1KMT2AIDO1HTTMAPT | |
| SCHEMBL9112000 | 0.76 | MEN1 (0.42) | MEN1KMT2AIDO1HTTMAPT | |
| SCHEMBL20425216 | 0.75 | IDO1 (0.47) | MEN1KMT2AIDO1HTTMAPT | |
| SCHEMBL16589112 | 0.75 | IDO1 (0.47) | MEN1KMT2AIDO1APPSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319213-A1 | FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS | ABX ADVANCED BIOCHEMICAL COMPOUNDS – BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH (DE) | 2025-10-16 | — | — | US | disclosed |
| EP-4529473-A1 | FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS | ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH (DE) | 2025-04-02 | — | — | EP | disclosed |
| WO-2023227535-A1 | FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS | ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH (DE) | 2023-11-30 | — | — | WO | disclosed |
| EP-4282438-A1 | FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS | ABX Advanced Biochemical Compounds GmbH (DE) | 2023-11-29 | — | — | EP | disclosed |
| EP-1956013-B1 | DIAGNOSTIC AND REMEDY FOR DISEASE CAUSED BY AMYLOID AGGREGATION AND/OR DEPOSITION | FUJIFILM RI PHARMA CO LTD (JP) | 2016-04-13 | — | — | EP | disclosed |
| EP-1956013-B1 | DIAGNOSTIC AND REMEDY FOR DISEASE CAUSED BY AMYLOID AGGREGATION AND/OR DEPOSITION | FUJIFILM RI PHARMA CO LTD (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-8022075-B2 | Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition | FUJIFILM RI PHARMA CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| US-8022075-B2 | Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition | FUJIFILM RI PHARMA CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| US-8022075-B2 | Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition | FUJIFILM RI PHARMA CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| US-20090162283-A1 | DIAGNOSTIC AND REMEDY FOR DISEASE CAUSED BY AMYLOID AGGREGATION AND/OR DEPOSITION | FUJIFILM RI PHARMA CO., LTD. (JP) | 2009-06-25 | — | — | US | disclosed |
| US-5951964-A | SCINTIGRAPHY; REAGENTS COMPRISED OF A MULTIPLICITY OF SPECIFIC-BINDING PEPTIDE MOIETIES HAVING AN AFFINITY FOR TARGETED SITES IN VIVO; POLYVALENT LINKAGES; KITS; DEEP-VENOUS THROMBI; CONTRAST; EFFICIENCY | DIATIDE, INC. (US) | 1999-09-14 | — | — | US | disclosed |
| EP-0637968-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | DIATIDE INC (US) | 1999-09-08 | — | — | EP | disclosed |
| US-5922303-A | SCINTIGRAPHIC IMAGING AGENT | DIATIDE, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| US-5849261-A | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy | DIATIDE, INC. (US) | 1998-12-15 | — | — | US | disclosed |
| US-5780007-A | USED FOR RADIODIAGNOSIS | DIATIDE, INC. (US) | 1998-07-14 | — | — | US | disclosed |
| US-5776428-A | Technetium-99m labeled peptides for imaging | DIATIDE, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5720934-A | MEDICAL DIAGNOSIS | DIATIDE, INC. (US) | 1998-02-24 | — | — | US | disclosed |
| WO-1995025720-A1 | PIPERIDYL-4-SUBSTITUTED THYROSINE DERIVATIVES AS SCINTIGRAPHIC IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOSIS | DIATECH, INC. (US) | 1995-09-28 | — | — | WO | disclosed |
| EP-0644778-A1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING. | DIATECH INC (US) | 1995-03-29 | — | — | EP | disclosed |
| WO-1993025244-A1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | DIATECH, INC. (US) | 1993-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319213-A1 | FUNCTIONALIZED BISAMINOTHIOL DERIVATIVES, COMPLEXES WITH THESE BISAMINOTHIOL DERIVATIVES AND USE OF SAID COMPLEXES AS DIAGNOSTICS AND THERAPEUTICS | MARS1, MARS2, BCAT1 | MEN1 81/4885KMT2A 590/4885IDO1 1647/4885 |
| US-20090162283-A1 | DIAGNOSTIC AND REMEDY FOR DISEASE CAUSED BY AMYLOID AGGREGATION AND/OR DEPOSITION | APP, TTR, BACE1 | MEN1 609/4885KMT2A 3062/4885IDO1 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.